alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

# Written Statement of
the Chief Executive Officer and Chief Financial OfficerPursuant to 18 U.S.C. §1350

Solely
for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, we, the undersigned President and Chief Executive
Officer and Vice President Law/Finance and Secretary of Ladish Co., Inc. (the
Company), hereby certify, based on our knowledge, that the Report on Form 10-Q
of the Company for the quarter ended June 30, 2008 (the Report) fully
complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and
that information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.

/s/ Kerry L. Woody   Kerry L. Woody
 President and Chief Executive Officer

/s/ Wayne E. Larsen  Wayne E. Larsen
Vice President Law/Finance & Secretary

August 1, 2008
# C_2015056EN.01002101.xml

| 16.2.2015 | EN | Official Journal of the European Union | C 56/21 |
| --- | --- | --- | --- |

16.2.2015

EN

Official Journal of the European Union

C 56/21

---

Order of the General Court of 12 December 2014 — Christian Dior Couture v OHIM (Representation of a pattern of squares with a honeycomb effect)

(Case T-313/14) (1)

1

((Community trade mark - Registration refused in part - Application for registration withdrawn in part - No need to adjudicate))

(2015/C 056/29)

Language of the case: French

Parties

Parties

Applicant: Christian Dior Couture SA (Paris, France) (represented by: M. Sabatier, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: S. Pétrequin and A. Folliard-Monguiral, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 4 March 2014 (Case R 459/2013-4), in relation to an application for international registration designating the European Union.

Operative part of the order

Operative part of the order

| 1. | There is no need to adjudicate on the action. |
| --- | --- |

1.

There is no need to adjudicate on the action.

| 2. | The applicant is ordered to pay the costs. |
| --- | --- |

2.

The applicant is ordered to pay the costs.

---

(1)  OJ C 223, 14.7.2014.

1

---
San Joaquin Valley Air Pollution Control District June 25, 2013

Appendix H: Notice of Publication

Annual Air Monitoring Network Plan



### APPENDIX H: Notices of PublicationSan Joaquin Valley Air Pollution Control District June 25, 2013

Appendix H: Notice of Publication

Annual Air Monitoring Network Plan This page intentionally blank
# C_2015228EN.01001302.xml

| 13.7.2015 | EN | Official Journal of the European Union | C 228/13 |
| --- | --- | --- | --- |

13.7.2015

EN

Official Journal of the European Union

C 228/13

---

Order of the General Court of 18 May 2015 — Ackermann Saatzucht and Others v Parliament and Council

(Case T-559/14) (1)

1

((‘Action for annulment - Regulation (EU) No 511/2014 - Compliance measures for users from the Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization in the Union - Lack of individual concern - Inadmissibility’))

(2015/C 228/16)

Language of the case: English

Parties

Parties

Applicant: Ackermann Saatzucht (Irlbach, Germany) and the other applicants listed in the annex to the order (represented by: P. de Jong, P. Vlaemminck and B. Van Vooren, lawyers)

Applicant:

Defendants: European Parliament (represented by L. Visaggio, J. Rodrigues and R. Van de Westelaken, acting as Agents); and Council of the European Union (represented by: M. Moore and M. Simm, acting as Agents)

Defendants:

Re:

Re:

Action for annulment of Regulation (EU) No 511/2014 of the European Parliament and of the Council of 16 April 2014 on compliance measures for users from the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization in the Union (OJ 2014 L 150, p. 59).

Operative part of the order

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | There is no need to rule on the application of the European Seed Association (ESA) for leave to intervene. |
| --- | --- |

2.

There is no need to rule on the application of the European Seed Association (ESA) for leave to intervene.

| 3. | Ackermann Saatzucht GmbH & Co. KG and the other applicants whose names appear in the annex are to bear their own costs and to pay those incurred by the European Parliament and the Council of the European Union. |
| --- | --- |

3.

Ackermann Saatzucht GmbH & Co. KG and the other applicants whose names appear in the annex are to bear their own costs and to pay those incurred by the European Parliament and the Council of the European Union.

---

(1)  OJ C 388, 3.11.2014.

1

---
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3950 Vancomycin test system. ( a ) *Identification.* A vancomycin test system is a device intended to measure vancomycin, an antibiotic drug, in serum. Measurements obtained by this device are used in the diagnosis and treatment of vancomycin overdose and in monitoring the level of vancomycin to ensure appropriate therapy.
( b ) *Classification.* Class II.
# C_2015221EN.01001102.xml

| 6.7.2015 | EN | Official Journal of the European Union | C 221/11 |
| --- | --- | --- | --- |

6.7.2015

EN

Official Journal of the European Union

C 221/11

---

Judgment of the General Court of 21 May 2015 — Evyap v OHIM — Megusta Trading (nuru)

(Case T-56/14) (1)

1

((Community trade mark - Opposition proceedings - Application for a Community figurative mark representing a wiggly line - Earlier national and international word and figurative marks DURU - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

(2015/C 221/15)

Language of the case: English

Parties

Parties

Applicant: Evyap Sabun Yağ Gliserin Sanayi ve Ticaret A.Ş. (Istanbul, Turkey) (represented by: J. Güell Serra, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: Ó. Mondéjar Ortuño, acting as Agent)

Defendant:

Other party to the proceedings before the Board of Appeal of OHIM: Megusta Trading GmbH (Zurich, Switzerland)

Other party to the proceedings before the Board of Appeal of OHIM:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 6 November 2013 (Case R 1861/2012-4) concerning opposition proceedings between Evyap Sabun Yağ Gliserin Sanayi ve Ticaret A.Ş. and Megusta Trading GmbH.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1) | Dismisses the action; |
| --- | --- |

1)

Dismisses the action;

| 2) | Orders Evyap Sabun Yağ Gliserin Sanayi ve Ticaret A.Ş. to pay the costs. |
| --- | --- |

2)

Orders Evyap Sabun Yağ Gliserin Sanayi ve Ticaret A.Ş. to pay the costs.

---

(1)  OJ C 129, 28.4.2014.

1

---
Exhibit 32.1

# Written Statement of
the Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C.
§1350

Solely
for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, we, the undersigned President and Chief Executive
Officer and Vice President Law/Finance and Secretary of Ladish Co., Inc. (the
Company), hereby certify, based on our knowledge, that the Report on Form 10-Q
of the Company for the quarter ended March 31, 2009 (the Report) fully
complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and
that information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.

/s/ Kerry L. Woody  Kerry L. Woody
President and Chief Executive Officer

/s/ Wayne E. Larsen Wayne E. Larsen 
Vice President
Law/Finance & Secretary

May 1, 2009
<PAGE>   1


                                                                    EXHIBIT 11.3

                             PAGEMART WIRELESS, INC.
                    COMPUTATION OF PER SHARE EARNINGS (LOSS)

<TABLE>
<CAPTION>
                                                            YEAR ENDED DECEMBER 31, 1997
                                                        --------------------------------------
                                                         NUMBER         PERCENT     EQUIVALENT
                                                        OF SHARES     OUTSTANDING     SHARES
                                                        ---------     -----------     ------
<S>                                                       <C>             <C>        <C>      
COMMON STOCK
   From Founders' Stock                                  2,300,000       100.00%    2,300,000
   Stock Options Exercised                                 731,072        90.01%      658,012
   Preferred Stock Converted to Common Stock            15,310,943       100.00%   15,310,943
   1994 Common Stock Offerings                          11,242,857       100.00%   11,242,857
   1995 Common Stock Offerings                           4,323,874       100.00%    4,323,874
   1996 Common Stock Offering                            6,000,000       100.00%    6,000,000
   Employee Stock Purchase Plan Shares Issued               75,891        59.41%       45,087
   1997 Warrants Exercised                                  48,300        84.33%       40,732
                                                       -----------                -----------
                                                        40,032,937                 39,921,505

WEIGHTED AVERAGE SHARES OUTSTANDING                                                39,921,505

NET LOSS                                                                         ($43,887,000)


NET LOSS PER SHARE                                                                     ($1.10)
                                                                                  ===========
</TABLE>
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.6675 Platelet aggregometer. ( a ) *Identification.* A platelet aggregometer is a device, used to determine changes in platelet shape and platelet aggregation following the addition of an aggregating reagent to a platelet rich plasma.
( b ) *Classification.* Class II (performance standards).
[45 FR 60608, Sept. 12, 1980]
I 

118TH CONGRESS 

2D SESSION H. R. 7718 

To amend title XVIII of the Social Security Act to assure pharmacy access 

and choice for medicare beneficiaries. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 19, 2024 

Mr. GALLEGO introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on 

Ways and Means, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL 

To amend title XVIII of the Social Security Act to assure 

pharmacy access and choice for medicare beneficiaries. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ASSURING PHARMACY ACCESS AND CHOICE 

4 FOR MEDICARE BENEFICIARIES. 

5 Section 1860D–4(b)(1) of the Social Security Act (42 

6 U.S.C. 1395w–104(b)(1)) is amended by striking subpara7 graph (A) and inserting the following: 

8 ‘‘(A) IN GENERAL.— 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7718 IH

1 ‘‘(i) PARTICIPATION OF ANY WILLING

2 PHARMACY.—A PDP sponsor offering a 

3 prescription drug plan shall permit any 

4 pharmacy that meets the standard contract 

5 terms and conditions under such plan to 

6 participate as a network pharmacy of such 

7 plan. 

8 ‘‘(ii) CONTRACT TERMS AND CONDI9 TIONS.— 

10 ‘‘(I) IN GENERAL.—For plan 

11 years beginning on or after January 

12 1, 2028, in accordance with clause (i), 

13 contract terms and conditions offered 

14 by such PDP sponsor shall be reason15 able and relevant according to stand16 ards established by the Secretary 

17 under subclause (II). 

18 ‘‘(II) STANDARDS.—Not later 

19 than the first Monday in April of 

20 2027, the Secretary shall establish 

21 standards for reasonable and relevant 

22 contract terms and conditions for pur23 poses of this clause. 

24 ‘‘(III) REQUEST FOR INFORMA25 TION.—Not later than January 1, 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7718 IH

1 2025, for purposes of establishing the 

2 standards under subclause (II), the 

3 Secretary shall issue a request for in4 formation to seek input on trends in 

5 prescription drug plan and network 

6 pharmacy contract terms and condi7 tions, current prescription drug plan 

8 and network pharmacy contracting 

9 practices, whether pharmacy reim10 bursement and dispensing fees under 

11 this part cover pharmacy ingredient 

12 and operational costs, areas in current 

13 regulations or program guidance re14 lated to contracting between prescrip15 tion drug plans and network phar16 macies requiring clarification or addi17 tional specificity, factors for consider18 ation in determining the reasonable19 ness and relevance of contract terms 

20 and conditions between prescription 

21 drug plans and network pharmacies, 

22 and other issues determined appro23 priate by the Secretary.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
**Exhibit 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE**

**SARBANES-OXLEY ACT OF 2002**

I, Sean P. Washchuk, certify that: 

1. I havereviewed this Annual Report on Form 10-K of Vitran Corporation Inc.; 

2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding thereliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors: 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’s internal control over financial reporting. 

Date: February9, 2011
EPA-420-F-11-009

 April 2011 

Independent Commercial Importers 

 The following is a list of Independent Commercial Importers (ICIs) who currently hold a valid 

certificate of conformity from EPA as of the date of this list. This certificate allows the ICI to import certain 

nonconforming vehicles into the United States. THE MAKES OR MODELS THAT AN ICI CAN IMPORT 

ARE LIMITED. You should contact the ICI to determine if he/she is qualified to import your particular 

vehicle and if they hold a current Certificate of Conformity. 

Auto Boutique Ltd. G & K Automotive J.K Technologies, LLC 

660 Baker St. 405-V Conversion, Inc. 3500 Sweet Air Street

Costa Mesa, CA 92626 2530 S. Birch Street Baltimore, MD 21211 

Rep: Makoto Harada Santa Ana, CA 92707 Rep: Jonathan Weisheit 

Phone: (714) 668-0235 Phone (714) 545-9503 Phone: (410) 366-6332 

Email: epa@autoboutique.us Fax: (714) 545-7667 Fax: (410) 366-7655 

 Email: george@gnkauto.com Email: convert2us@aol.com

Northern California Right Hand Drive Japan US Drive Right

Diagnostic Laboratories, Inc. 20437 Hawthorne Blvd P.O. Box 492 

2748 Jefferson Street Torrance, CA 90503 Spring Arbor, MI 49283 

Napa, CA 84558-4936 Rep: Takahiro Fujimori Rep: Bruce Hildenbrand 

Rep: Mike Spencer-Smith Phone: (310) 452-4299 Phone: (517) 206-4486 

Phone: (707) 258-1753 Email: Email: bruce@usdriveright.com

Fax: (707) 258-1611 info@righthabddrivejapan.com

Email: ncdl@ncdlinc.com

US SPECS, LLC Wallace Environmental 

121Northway Drive Testing Laboratories 

Havre de Grace, MD 21078 2140 Wirtcrest 

Rep: Carl Brinegar Houston, TX 77055 

Phone: (443) 502-2331 Rep: Les Weaver

Fax: (443) 502-2331 Phone: (713) 956-7705 

Email: USSPECS@aol.com Fax: (713) 956-0104 

 Email: sales@wallacelab.com

 EPA DOES NOT ENDORSE OR RECOMMEND ANY PARTICULAR ICI ON THIS LIST. EPA 

cautions that an ICI’s capability to bring a vehicle into conformity with U.S. emission requirement does not 

guarantee that in individual cases the work will be properly performed. Test documentation for an individual 

vehicle and other information concerning the quality of modifications will be carefully scrutinized to 

determine whether such vehicle meets all applicable EPA requirements under the imports regulations.
| (logo) NTS NATIONAL

TAX SEARCH, LLC | 303 E Wacker Drive, Suite 900

Chicago, IL 60601

(312) 233-6440 |
|--------------------------------------|------------------------------------------------------------------|

 

 

REPORT ON ASSESSMENT OF COMPLIANCE WITH APPLICABLE SECURITIES AND

EXCHANGE COMMISSION'S REGULATION AB SERVICING CRITERIA

 

 

For the calendar year ending December 31, 2015, National Tax Search, LLC has been a Tax Service Vendor for **Wells Fargo Bank** (the "Servicer").

 

National Tax Search, LLC ("NTS") is responsible for assessing compliance as of December 31, 2015 and for the period from January 1, 2015 through December 31, 2015 (the "Reporting Period") with the servicing criteria set forth in Title 17, Section 229.1122(d) of the Code of Federal Regulations (the "CFR''). NTS has used the servicing criteria communicated to NTS by the Servicer to assess compliance with the applicable servicing criteria. Only servicing criteria 1122 (d) (l)(ii), 1122 (d)l(iv), 1122 (d)2(ii), 1122 (d)2(v), 1122(d)2(vi), 1122 (d)2(vii), 1122(d)(4)(xi), and 1122(d)(4)(xii) (the "Applicable Servicing Criteria") are applicable to the activities NTS performs with respect to the transactions covered by this report. NTS has determined that the remaining servicing criteria set forth in Item 1122 (d) of the SEC Regulation AB are not applicable to the activities it performs with respect to the transactions covered by this report. The transactions covered by this report include all tax payments made on behalf of the Servicer using NTS's TaxQ system (the "Platform Transactions").

 

NTS, as a vendor, has assessed its compliance with the Applicable Servicing Criteria for the Reporting Period and has concluded that the NTS has complied, in all material respects, with the Applicable Servicing Criteria as of December 31, 2015 and for the Reporting Period with respect to the Platform Transactions taken as a whole.

 

Plante & Moran, PLLC, an independent registered public accounting firm, has issued an attestation report on 'the assessment of compliance with the Applicable Servicing Criteria as of December 31, 2015 and for the Reporting Period as set forth in this assertion.

 

 

National Tax Search, LLC, as Vendor to Servicer

/s/ Lori D. Eshoo

Lori D. Eshoo, President/CEO

January 18, 2016
# C_2015381EN.01002901.xml

| 16.11.2015 | EN | Official Journal of the European Union | C 381/29 |
| --- | --- | --- | --- |

16.11.2015

EN

Official Journal of the European Union

C 381/29

---

Order of the General Court of 25 September 2015 — Kolarova v REA

(Case T-533/14 P) (1)

1

((Appeals - Civil service - Member of the contract staff - REA - Powers conferred on the authority authorised to conclude contracts of employment - Delegation to the Office for the Administration and Payment of Individual Entitlements (PMO) - Appeal directed against the delegating institution - Appeal clearly inadmissible in part and clearly unfounded in part))

(2015/C 381/31)

Language of the case: French

Parties

Parties

Appellant: Desislava Kolarova (Brussels, Belgium) (represented by: F. Frabetti, lawyer)

Appellant:

Other party to the proceedings: Research Executive Agency (REA) (represented by: S. Payan-Lagrou, acting as Agent, assisted by B. Wägenbaur, lawyer)

Other party to the proceedings:

Re:

Re:

Appeal brought against the Order of the Civil Service Tribunal of the European Union (Third Chamber) of 30 April 2014 in Kolarova v REA (Case F-88/13, ECR-SC, EU:F:2014:58), and seeking that that order be set aside.

Kolarova

REA

Operative part of the order

Operative part of the order

The Court:

| 1. | Dismisses the appeal. |
| --- | --- |

1.

Dismisses the appeal.

| 2. | Orders Mrs Desislava Kolarova to bear her own costs and pay those incurred by the Research Executive Agency (REA) on the appeal. |
| --- | --- |

2.

Orders Mrs Desislava Kolarova to bear her own costs and pay those incurred by the Research Executive Agency (REA) on the appeal.

---

(1)  OJ C 351, 6.10.2014.

1

---
§ 80.38 Treatment of batch after certification. ( a ) Immediately upon notification that a batch of color additive has been certified, the person requesting certification thereof shall identify such batch, by labeling, with the certified lot number.
( b ) The person requesting certification shall maintain storage in such manner as to prevent change in composition until such batch has been packaged and labeled as required by §§ 70.20 and 70.25 of this chapter, except that the person requesting certification may use such color additive for the purpose of coloring a food, drug, or cosmetic.